Cerus Corporation is a biomedical products company focused on developing and commercializing innovative blood transfusion safety systems based on its Intercept Blood System. The company's products are designed to enhance the safety of blood transfusions by reducing the risk of transfusion-transmitted infections, including hepatitis B and C, HIV, West Nile virus and bacterial contamination, as well as potentially transfusion-related diseases, such as graft-versus-host disease.